Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing
about
Neonatal tolerant immunity for vaccination against autoimmunity.Multi-modal antigen specific therapy for autoimmunity.T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis.Neonatal Basophils Stifle the Function of Early-Life Dendritic Cells To Curtail Th1 Immunity in Newborn Mice.Bone marrow-derived IL-13Rα1-positive thymic progenitors are restricted to the myeloid lineage.Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes.Antigen-specific inhibition of CD4(+) T-cell responses to β-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism.Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitisOn the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunityHigh frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire.Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergyInnocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 productionIn trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses.Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity.Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells.Antigen-Specific Immune Modulation Targets mTORC1 Function To Drive Chemokine Receptor-Mediated T Cell Tolerance.
P2860
Q33891071-D5D7C257-E776-40D2-B032-249312E7931CQ34560522-E8125E46-8E44-41A5-94BD-B6E777E1CD2DQ35269080-84EA08F4-FA60-4437-B654-D2A653EDC86AQ35816043-8195762E-C07D-4A29-AAC3-960DF4A0CCDCQ35850794-C11F9768-ACA1-4300-B554-2CBB2EC58138Q36257660-057D3699-1649-4431-96AA-EC1FDDC36AB4Q36304701-1C24B241-B236-43F3-ABC5-AA7F1E22F47BQ36368628-5AFFAA9B-114C-44E9-ACA3-A6DE034A64CEQ36370816-1BFD2550-8AE8-482B-9CA8-FC2DE789DDF1Q36376026-60DA0E32-9D1C-46EA-AA7D-0BB1E475048FQ36401218-3F28FFF8-D1B3-4F67-9773-BE58D11A6E80Q36446935-0D182AB9-773C-4EF8-ACDE-793E195F4C53Q36604008-EDBE0AED-8AF8-4192-8E22-C7EA4313600FQ36916344-FD51B887-DA33-4601-B824-2A4BBB01D7FAQ37184056-2202FBC3-2ABC-495C-9B9E-85E9D6C3651BQ42578734-DB403B4D-397A-40CA-AE86-D997DE609096
P2860
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Presentation of a T cell recep ...... requiring endocytic processing
@ast
Presentation of a T cell recep ...... requiring endocytic processing
@en
type
label
Presentation of a T cell recep ...... requiring endocytic processing
@ast
Presentation of a T cell recep ...... requiring endocytic processing
@en
prefLabel
Presentation of a T cell recep ...... requiring endocytic processing
@ast
Presentation of a T cell recep ...... requiring endocytic processing
@en
P2093
P2860
P356
P1476
Presentation of a T cell recep ...... requiring endocytic processing
@en
P2093
P2860
P304
P356
10.1084/JEM.185.6.1043
P407
P577
1997-03-01T00:00:00Z